Letter to Utah Congressional Delegation RE: H.R. 3, The Lower Drug Costs Now Act

May 25, 2021

Today, BioUtah, in conjunction with Centro Civico Mexicano, First Step House, International Cancer Advocacy Network, Mental Healthy FIT, Northern Utah Coalition, and Patel Family Investments, sent a letter to Utah’s congressional delegation expressing concern with the reintroduction of H.R. 3, The Lower Drug Costs Now Act. In the letter, the coalition states its concern about the bill’s negative impact on investment in drug discovery.

You may read the letter in its entirety here.